The mission-driven leader in longevity and telehealth earns national recognition on the 2025 Inc. 5000 list for its rapid revenue and membership growth.
Ann Arbor, MI, August 12, 2025 – AgelessRx, a pioneer in longevity and telehealth solutions, has been named to Inc. Magazine’s annual ranking of the fastest-growing private companies in America. The ranking is based on revenue growth over 3 years, highlighting companies reshaping their industries through steady growth and future-thinking business models.
First published 44 years ago, the Inc. 5000 list is a long-running measure of private business success and is considered America’s entrepreneurial benchmark. Each year, Inc. highlights companies from a variety of industries that show strong growth and staying power. AgelessRx joins a group of past recipients that includes well-known names like Microsoft, Zappos, Intuit, Patagonia, and Under Armour.
“We’re honored by Inc.’s recognition, not just for our rapid growth, but for what it represents,” said Anar Isman, CEO and co‑founder of AgelessRx. “It reflects the growing momentum behind a core belief: aging is a disease worth treating, and radically extended healthspan should be the new default. That shift is driving our progress, and we’re here to accelerate it.”
Established in 2020, AgelessRx is shifting healthcare from reactive to preventive. The first-of-its-kind platform, built specifically for longevity-focused care, makes personalized, healthspan boosting protocols accessible by weaving together prescription therapies, advanced diagnostics, targeted supplements, and expert clinical guidance into a single digital hub.
Backed by a Stanford PhD-led Applied Sciences team who both runs clinical trials and vets protocol effectiveness, each protocol is tailored to the individual, guided by US-based clinicians, and continuously updated over time using patient data and real-world outcomes to promote healthspan.
Earlier in the year, AgelessRx was also named to Inc.’s 2025 Best Workplaces list, a testament to its mission-first culture and values-driven growth.
“For us, growth has always been about impact,” said Courtney Frederick, Vice President of People and Finance. “This honor reflects the work of a dedicated team that’s stayed grounded in why we started, our mission, and who we’re here to help. That’s what makes this moment meaningful.”
The Story Behind AgelessRx
AgelessRx was founded by CEO Anar Isman, who spent fifteen years in investment funds before turning his focus to longevity. After struggling to get a physician to prescribe his mother a medication with potential longevity benefits, he saw firsthand how difficult it was for healthy people to access treatments aimed at extending healthspan rather than treating a single diagnosis. That experience led him to partner with a physician co-founder known as Dr. Z, and later with Jonn Behrman, to build a platform that could make science-backed longevity support more accessible.
In its early years, AgelessRx also helped organize and fund PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity), one of the first large-scale, nationwide telemedicine trials studying rapamycin for longevity, run in affiliation with the University of California with Dr. James Watson at UCLA as principal investigator. The double-blind, placebo-controlled study was designed to evaluate whether rapamycin may support healthy aging in adults, combining extensive lab testing with donor and crowdfunding support to help get the research off the ground.
The global longevity market is expected to reach $63 billion by 2035, with a CAGR of 10.37%, as consumer demand continues to grow for prevention-first care models. AgelessRx is leading the way in science-backed, human-first longevity care with a model that’s data-driven, personalized, comprehensive, and accessible, shaping the future of what modern aging can be.